ArticleThe Biochemical journal2006
Role of HNF4alpha in the superinduction of the IL-1beta-activated iNOS gene by oxidative stress.
Article in The Biochemical journal, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 5 citations in OpenAlex.
- High iNOS and IL-1β immunoreactivity are features of colitis-associated colorectal cancer tumors, but fail to predict 5-year survival.Upsala journal of medical sciences · 2023Article
- Dynamic transcriptomic profiles of zebrafish gills in response to zinc depletion.BMC genomics · 2010Article
Corrections and comments
- Comment on
Authors and funding
1 author at 1 institution in 1 country.
Funding
Abstract
IL-1beta (interleukin-1beta) treatment of hepatocytes results in an NF-kappaB (nuclear factor-kappaB)-mediated activation of the iNOS (induced nitric oxide synthase) gene, and this increase in gene expression is further augmented by oxidative stress. Oxidative stress alone has no influence on the iNOS promoter, therefore indicating that the promoter needs to be primed by NF-kappaB. In this issue of the Biochemical Journal, Guo et al. extend their earlier work, showing that HNF4alpha (hepatocyte nuclear factor 4alpha) mediates the superinduction of iNOS observed by co-treating cells with IL-1b plus H2O2. A specific phosphorylation by p38 kinase at Ser-158 of HNF4alpha results in increased binding of HNF4alpha to the iNOS promoter, leading to enhanced transcription. The study by Guo et al. is the first to show definitively that HNF4alpha can be modulated to differentially activate specific genes. However, issues remain to determine the functional significance in vivo of the elevated iNOS activity, and the mechanism that governs the specificity of HNF4alpha towards the iNOS promoter element as compared with many other HNF4alpha target genes in the hepatocyte.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.